Navigation Links
35th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser
Date:10/4/2010

the way Phase-I and Phase-II cancer clinical trials are designed. Researchers report finding unexpectedly large differences in the lists of drugs that trial designers say participants should not be given to avoid potentially dangerous drug-drug interactions.

T. Mok, CN

New Phase-II study shows first-line promise of lung cancer drug PF-299 (embargo: 11 October, 13:15 Milan time)

A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease.

A. Necchi, IT

Pazopanib shows promise in Phase-II trial for relapsed/refractory urothelial cancer (embargo: 11 October, 13:30 Milan time)

An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results.

J. Vermorken, NL

Panitumumab fails to add overall survival benefit in recurrent/metastatic head and neck cancer: full Phase-III results (embargo: 11 October, 13:30 Milan time)

Adding the monoclonal anti-EGFR antibody panitumumab to chemotherapy did not significantly improve overall survival for patients with recurrent and/or metastatic head and neck cancer, according to Phase-III trial results.

J. Baselga, US

Adding cetuximab to chemotherapy doubles response rate in hard-to-treat breast cancer (embargo: 11 October, 15:00 Milan time)

For the first time researchers have proven that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat "triple negative" breast cancer.

E. Perez, US

New type of targeted therapy shows promise as first-line therapy for HER2-positive metastatic breast cancer (embargo: 11 October, 15:00 Milan time)

A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease.

J. De Bono,
'/>"/>

SOURCE European Society for Medical Oncology (ESMO)
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
2. European Masters of Poker Italy Online Qualification in Full Swing
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CVS Caremark Recognizes Its 26,000 Pharmacists During Octobers American Pharmacists Month
5. American College of Surgeons Clinical Congress Convenes in Washington, DC, October 3-7, 2010
6. Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010
7. Stryker to Host Conference Call on October 19, 2010
8. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
9. Solos Endoscopy, Inc. Reports Sales Increase for October 2009 and November 2009 as Compared to Same Two Months in 2008
10. Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase
11. Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , Engeland, May 23, 2013 ... mannen met lagere urinewegsymptomen geassocieerd met BPH ... Europese dochteronderneming van Astellas Pharma Inc, gebaseerd in ... 4503), kondigde vandaag aan dat het Nederlandse College ter ... VESOMNI in Nederland. De handelsvergunning verleend voor ...
(Date:5/23/2013)... Mai 2013 Ranbaxy Laboratories ... von Daiichi Sankyo Co., Ltd. (im ... Mai die Maßnahmen bekannt, die Ranbaxy ... um sich der Angelegenheiten der vorhergehenden ... ). Daiichi Sankyo unterstützt ...
(Date:5/22/2013)... LOVELAND, Colo. , May 22, 2013  Heska Corporation ... veterinary diagnostic and specialty products, announced today that the Company ... on Wednesday, May 29, 2013 at the Le Parker Meridian ... New York City . The presentation is scheduled to ... About Heska Heska Corporation (NASDAQ: ...
Breaking Medicine Technology:Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... March 3, 2011 Tom McLeer, GM of Spine and ... in Marquette, MI, announces the appointment of Jim St. John ... Jim has 25 years of experience in the spine industry; ... 5 languages.  Jim last worked for Benvenue Medical where he ...
... March 3, 2011 InstaCare Corp. (OTC Bulletin Board: ... drugs, home testing products for the chronically ill, a ... and a leading developer of revolutionary patent pending cell ... announced that it has migrated its recently patent pending ...
Cached Medicine Technology:Pioneer® Surgical Announces New International Sales V.P. 2InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 2InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 3
(Date:5/23/2013)... Until now, little was scientifically known about the human ... caring for people who are suffering in a way ... by researchers at the Center for Investigating Healthy Minds ... shows that adults can be trained to be more ... Psychological Science , is the first to investigate ...
(Date:5/23/2013)... New techniques in imaging of brain activity developed ... Neurological Institute, and his colleagues lead to improved ... combination of electroencephalogram (EEG) and functional magnetic resonance ... the areas generating epileptic seizures, giving neurosurgeons a ... if appropriate. These results were presented at ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- Physicians weighing the benefits ... have more information to help with the decision. A new ... scans pick up significantly more lung tumors than chest X-rays ... at high risk for lung cancer, the deadliest form of ... the potential harm of radiation exposure when ordering screening. ...
(Date:5/23/2013)... 2013 Located at 22343 La Palma Ave. ... Linda held its Grand Opening Family Fun Charity event on ... multiple sclerosis and physical fitness. Sponsored by many different vendors ... the fun filled Grand Opening featured mini boot camp sessions ... community what the Yorba Linda fitness center has ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... to announce the launch of Current Digital, a ... web development and digital marketing needs. Companies now ... a strategic business necessity. This can often leave ... creative strategy on preselected software platforms that they ...
Breaking Medicine News(10 mins):Health News:Study shows people can be trained to be more compassionate 2Health News:Study shows people can be trained to be more compassionate 3Health News:Study shows people can be trained to be more compassionate 4Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 2Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 3
... Bradford, from Oswestry, a patient with breast cancer in England ... are given free drug treatment// at a hospital. Local health ... the Shropshire Primary Care Trust. The patients in Shropshire have ... protest at the hospital on Monday. ,North Shropshire ...
... London, the cause of autism may now be explained due t ... not interacting well with other people. Weak links between brain areas ... situations as well as other people. ,The study ... an Autism Spectrum Disorder (ASD) while the other 16 did not. ...
... NHS trust failed to adequately supervise two doctors. Amit ... Hospital. It led to the death of the patient ... surgery. He suffered toxic shock syndrome. The hospital ... house officers. ,At a sentencing hearing at ...
... According to a new study of women with early stage, ... disease have been identified that may influence how patients are ... patients from 1988 to 2002 was reviewed by Cancer Research ... are risk factors for invasive disease and the pattern of ...
... Office (NHSO) has found that women aged above 35 are ... should annually undergo a Pap smear test for early detection ... is the most common type of cancer among women. ... scheme, has provided Pap smear services to 1.5 million women ...
... heart's largest artery, the aorta. Studies were going on to ... Johns Hopkins University// have successfully come up with the treatment. ... in recent studies for treating the genetic disorder. The ... appears to prevent the weakening of the heart's largest artery, ...
Cached Medicine News:Health News:Cancer Patients Protest For Free Drug Treatment 2Health News:Lack Of Communication Between Brain Areas Can Cause Autism 2
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
... Designed for precise punching of the ... designed for use with disposable trephine ... aids in centration of the donor ... block is held centrally under the ...
Broad Tip and Ultra-Micro Needle Tip, sterile, 10 per Box, 10 Boxes per Case...
Medicine Products: